Pages that link to "Item:Q1029784"
From MaRDI portal
The following pages link to A review of phase 2-3 clinical trial designs (Q1029784):
Displaying 7 items.
- A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054) (← links)
- Methodology and application of adaptive and sequential approaches in contemporary clinical trials (Q1929694) (← links)
- Impacts on type I error rate with inappropriate use of learn and confirm in confirmatory adaptive design trials (Q3076083) (← links)
- Interphase Clinical Trials: Phase III/Phase IV (Q4937306) (← links)
- Phase 2 and 3 Combination Designs to Accelerate Drug Development (Q5754831) (← links)
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen (Q5901511) (← links)
- Hybrid design evaluating new biomarkers when there is an existing screening test (Q6627744) (← links)
